![Kjell Olmarker](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kjell Olmarker
Corporate Officer/Principal chez University of Gothenburg
Postes actifs de Kjell Olmarker
Sociétés | Poste | Début | Fin |
---|---|---|---|
University of Gothenburg | Corporate Officer/Principal | - | - |
Historique de carrière de Kjell Olmarker
Anciens postes connus de Kjell Olmarker
Sociétés | Poste | Début | Fin |
---|---|---|---|
STAYBLE THERAPEUTICS AB | Directeur/Membre du Conseil | 01/01/2015 | - |
Fondateur | 01/01/2015 | - | |
PharmaSurgics In Sweden AB
![]() PharmaSurgics In Sweden AB Pharmaceuticals: MajorHealth Technology PharmaSurgics is a clinical stage biotech company developing novel treatments for the prevention of harmful scarring (adhesions) after surgery. Post-surgical adhesions develop in millions of patients every year and are a source of great patient suffering and enormous healthcare expenditures. The company was founded in 2005 after extensive research done by Dr Inger Mattsby-Baltzer, PhD and Professor Kjell Olmarker MD, PhD at the Sahlgrenska Academy. PharmaSurgics is based in Göteborg, Sweden, where comprehensive in vitro and in vivo facilities have been established. | Directeur/Membre du Conseil | 01/01/2005 | - |
Fondateur | 01/12/2009 | - |
Statistiques
Internationale
Suède | 4 |
Opérationnelle
Director/Board Member | 2 |
Founder | 2 |
Corporate Officer/Principal | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
STAYBLE THERAPEUTICS AB | Health Technology |
Entreprise privées | 1 |
---|---|
PharmaSurgics In Sweden AB
![]() PharmaSurgics In Sweden AB Pharmaceuticals: MajorHealth Technology PharmaSurgics is a clinical stage biotech company developing novel treatments for the prevention of harmful scarring (adhesions) after surgery. Post-surgical adhesions develop in millions of patients every year and are a source of great patient suffering and enormous healthcare expenditures. The company was founded in 2005 after extensive research done by Dr Inger Mattsby-Baltzer, PhD and Professor Kjell Olmarker MD, PhD at the Sahlgrenska Academy. PharmaSurgics is based in Göteborg, Sweden, where comprehensive in vitro and in vivo facilities have been established. | Health Technology |
- Bourse
- Insiders
- Kjell Olmarker
- Expérience